Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease

American Heart Journal

Volumn 144, Issue 2, 2002, Pages 226-232

  McCullough, Peter A ^a   Sandberg, Keisha R ^b   Borzak, Steven ^b   Hudson, Michael P ^b   Garg, Mukesh ^a   Manley, Harold J ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSIS; DRUG EFFECT; DRUG USE; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SHOCK; ST SEGMENT ELEVATION;

EID: 0036348001     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.125513     Document Type: Article

References (25)

1. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction
2. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction
3. Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the cooperative cardiovascular project
4. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction
5. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization
6. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality
7. Preoperative renal risk stratification
8. Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased risk of stroke
9. Bleeding time in uremia: A useful test to assess clinical bleeding
10. Aspirin prolongs bleeding time in uremia by a mechanism distinct from cyclooxygenase inhibition
11. Management of patients with chronic renal insufficiency in northeastern United States
12. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency
13. The Henry Ford Health System
14. Henry Ford Health System medical information management system: Strategy for creating a community-wide health information system
15. Risks associated with renal dysfunction in coronary care unit patients
16. Prediction of creatinine clearance from serum creatinine
17. Predictability of creatinine clearance estimates in critically ill patients
18. Geriatric renal function: Estimating glomerular filtration in an ambulatory elderly population
19. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
20. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
21. Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality
22. Cardiovascular disease risk profiles
23. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
24. Beta-blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: Evidence from the AIRE study
25. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?